<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">Colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) express the WNT effector protein Î²-catenin in a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> subcellular pattern rather than uniformly in the nucleus </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated this important aspect of molecular <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> by analyzing its basis and relationship with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-initiating capability </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells with the highest WNT levels showed only a marginal increase in <z:e sem="disease" ids="C0598935" disease_type="Neoplastic Process" abbrv="">tumor initiation</z:e> capacity </plain></SENT>
<SENT sid="3" pm="."><plain>Notably, high WNT activity correlated with a coincident activation of robust <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase (MAPK) signaling, which when upregulated by KRAS expression or downregulated by epidermal growth factor receptor inhibition elicited parallel effects on WNT activity </plain></SENT>
<SENT sid="4" pm="."><plain>These findings suggested that on its own high WNT activity may not be a reliable signifier of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-initiating potential or stem-like potential </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, they suggest that MAPK signaling is a critical modifier of intratumoral <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> that contributes significantly to determining the impact of WNT activity on stemness phenotypes in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells </plain></SENT>
</text></document>